🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

@SandraMcAllist4 and I are finalists for the BRIght Futures Prize; would appreciate your vote to help us secure support to further our work looking at racial differences in the immune system and implications for development of breast cancer Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center

It's here and... waited for all embargoes to be lifted ... #neoadjuvant #melanoma SWOG Cancer Research Network #S1801 callback to ESMO - Eur. Oncology tag #neoadjuvanté 😉 A great team effort SWOG Cancer Research Network, @NCICTEP_ClinRes, NCTN, NCORPs - & ‼️ example of how cooperative groups can succeed! 💫 nejm.org/doi/full/10.10…

FDA broadens label for adjuvant abemaciclib, removing Ki67 score for patient selection! Great news, and makes sense given benefit seen irrespective of Ki67 in monarchE OncoAlert #bcsm investor.lilly.com/news-releases/…

We are leading a randomized Phase 2 trial for stage 1 HER2+ #breastcancer of T-DM1 followed by SQ trastuzumab versus TH (paclitaxel + SQ trastuzumab) (#ATEMPT 2.0). For more information call 877-338-7425 or visit: dana-farber.org/clinical-trial…

Dr. Hal Burstein (Harold J. Burstein, MD, PhD, FASCO) starting off the 2024 #HarvardBreastCancerCourse with the welcome remarks. cmecatalog.hms.harvard.edu/breast-cancer-…

Paula Steeves, Jade Moran and Lindsay Northrop shared patient perspectives at the #BreastCancer: New Horizons, Current Controversies Course discussing patient burdens and care gaps in otherwise excellent care. #HarvardBreastCancerCourse

Elevating value in cancer care. Precision medicine in breast cancer, moderated by Dr Sarah Sammons , expert panel Harold J. Burstein, MD, PhD, FASCO Ada Waks Dr. Hassett. Dana-Farber’s Breast Oncology Center leading value-based oncology AJMC

A huge day for spatial omics of cancer, tracing the precise origin and evolution of 20 types of cancer, many in 3D, in ~2,000 individuals, with 12 publications nature Nature Cancer Nature Medicine Nature Methods Communications Biology Collection nature.com/immersive/d428…

📢 Out in Nat Med: Single-cell, nucleus & 4 types of spatial expression data across the clinicopathological diversity of metastatic breast cancer! We find surprising within-patient stability, spatial EMT phenotypes, local immune exclusion, and more + comparison across methods🔗➡️

State-of-the-art single-cell and spatial profiling methods can reveal new insight into the diversity of cells in metastatic breast cancer. The new work can also help scientists design future experiments. broad.io/MBC-news

PRESS RELEASE: New insights from 10 Human Tumor Atlas Network studies provide critical information on how cancer tumors develop, spread, and respond to treatments. The research is to be published tomorrow in Nature Cancer. Learn more: go.nih.gov/YN70LjH #CancerMoonshot #HTAN

Excited to share our latest work in Nature Medicine as part of #HTAN to generate a spatial and cellular map of metastatic breast cancer with important technical, translational, and biological implications and multidisciplinary utility as a resource: rdcu.be/dYAVP

Simultaneous Nature Medicine pub of 2 neoadjuvant chemo-IO trials for high-risk ER+ BC: KN-756 & CM-7FL. Both found a striking improvement in pCR rate with IO, with larger Δ if PD-L1+ or low ER. Waiting for EFS data, which will most likely impact practice. nature.com/articles/s4159…

📢Our new package SlideCNA for spatial copy number alteration detection in spatial transcriptomics data is now out in Genome Biology: doi.org/10.1186/s13059…

New study in ESMO Open examines clinicopathological features and genomics of ER-positive/HER2-negative #BreastCancer relapsing on adjuvant #abemaciclib. 🔓pubmed.ncbi.nlm.nih.gov/40466434/ ✍️Chiara Corti Daniel Abravanel, MD/PhD Paolo Tarantino G Curigliano MD PhD Tari King MD Dr. E Mittendorf Nancy Lin, MD Sara Tolaney

We’re proud to announce that Elizabeth Mittendorf, MD, will join BIDMC as Chief of a new Division of Breast Surgery! 👏 A renowned surgeon, she will bring bold leadership to our growing program in collaboration with Dana-Farber. Learn more: bidmc.org/about-bidmc/ne…

📢Reminder! The #HarvardBreastCancerCourse is next week on July 17 & 18! Check out our hashtag to see past speakers and topics. Register today to attend in person or virtually ⬇️⬇️ learn.hms.harvard.edu/programs/breas…

The #HarvardBreastCancerCourse starts on Thursday! 📅July 17 & 18 📍Westin Copley Place, Boston, MA The Harvard Medical School #BreastCancer course is well suited for medical, surgical & radiation oncologists; breast & general surgeons; internists; physician assistants; nurse practitioners,

Starts Thursday. Register for in person or virtual participation. Will be awesome .

Welcome to Day 2 of the #HarvardBreastCancerCourse! We have exciting sessions lined up on Surgery, Immunotherapy, #TrippleNegativeBreastCancer, ER+ #BreastCancer, a debate on CDK4/6 and ASCO highlights! Harold J. Burstein, MD, PhD, FASCO